We are pleased to announce the 22nd international congress of the European Society of Toxicology In Vitro (ESTIV 2024), taking place 3 – 6 June 2024 in Prague, Czech Republic.

The ESTIV 2024 congress will be held in the Cubex Centre in Prague. With its rich cultural heritage, breathtaking architecture, and historical charm, Prague offers the perfect backdrop for ESTIV 2024. Immerse yourself in the vibrant atmosphere of this captivating city while connecting with peers, forging new collaborations, and building lasting professional relationships.

The general theme of the congress is “Applications of NAMs in Drug Discovery and Drug and Chemical Safety Assessment”. 

Your input on the program is important to us and we invite you to submit a late-breaking abstract for the congress. 

Late-breaking abstracts can be submitted within the following topics:

• Bio-engineering, stem cells and disease models 
• Models, biomarkers and assays for endocrine disruption 
• Models, biomarkers and assays for systemic and immune toxicity 
• Models, biomarkers and assays for developmental toxicity 
• Cardiotoxicity and cardiac efficacy models
• Local toxicity testing (safety and efficacy)
• Case studies for successful use and implementation of complex in vitro models
• Challenges in cosmetics safety 
• Organ-on-a-chip & Microphysiological Systems 
• Regulatory considerations for complex NAMs
• Computational toxicology – in silico modelling, read-across, artificial intelligence and machine learning 
• Toxicokinetics and in vitro – in vivo extrapolation
• In vitro systems to assess respiratory toxicity
• Non-animal methods for safety testing of biopharmaceuticals/biotherapies/vaccines 
• Knowledge sharing and education
• Funding the development, validation and implementation of NAMs
• ECHA, EMA and EFSA perspectives on the use of NAMs 
• In vitro and in silico methods for safety assessment of medical devices 
• Role of 3R centres in the dissemination and implementation of NAMs 
• Other 

The online late-breaking abstract submission module is now open and can be found here including detailed instructions.

Submission Deadline: 29 February 2024

We look forward to your input. Do not hesitate to get in touch with ideas, suggestions, comments or questions you might have regarding the congress, its programme or its organisation.

In addition, we would be delighted to welcome you as a Sponsor!   

Why Sponsor?

• Put your Business in the Spotlight
• Get your Brand Noticed
• New Clients, New Customers, New Business
• Market your Business Inexpensively
• Develop your Products and Services
• Find Vendors and Solution Providers

Sponsorship of ESTIV 2024 is an excellent way to keep your company’s name out front. We offer Gold, Silver, Bronze, and Exhibitor levels. In addition, you can also choose from a variety of A-La-Carte Sponsorship opportunities, in case you do not wish to exhibit. 

Please find below the Sponsorship Brochure:

Floorplan available!

The Exhibition Floorplan is now available. You can book your exhibition hall space by sending your preferred booth space number to estiv@klinkhamergroup.com.

If you have not registered as sponsor, please do so as soon as possible as exhibition floor allocations will be based on a first come/first serve basis.

* For best space selection, reserve your booth space now! *

The following link will take you to the Exhibition Floorplan.

Interested?

You will find the online registration module by clicking on the below button.

Questions

If you have any queries or if you need further information about the congress, please contact the congress secretariat via estiv@klinkhamergroup.com. 

Looking forward seeing you all in 2024 at ESTIV 2024 Congress in Prague.

On behalf of the organizing committee,
Helena Kandárová  - Congress Chair - President ESTIV
Clive Roper - Congress Chair - Vice President ESTIV

 We look forward to reunite with you and all your colleagues in the area of in vitro and in silico toxicology! 

Spread the word, invite your colleagues and share the information, because sharing is caring.